These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1169 related items for PubMed ID: 17694416

  • 1. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [Abstract] [Full Text] [Related]

  • 2. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
    Takahashi H, Nakamori S, Nakahira S, Tsujie M, Takahshi Y, Marubashi S, Miyamoto A, Takeda Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M.
    Ann Surg Oncol; 2006 Jul; 13(7):955-60. PubMed ID: 16788757
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [Abstract] [Full Text] [Related]

  • 6. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas.
    Nakagohri T, Asano T, Kenmochi T, Urashima T, Ochiai T.
    World J Surg; 2002 Sep; 26(9):1166-9. PubMed ID: 12045867
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K, Tanaka M.
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [Abstract] [Full Text] [Related]

  • 10. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
    Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB.
    Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
    [Abstract] [Full Text] [Related]

  • 11. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [Abstract] [Full Text] [Related]

  • 12. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kobayashi S, Kojima M, Miyauchi H, Asano T.
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.
    Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, Kanzaki A, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakamura S, Nakao A.
    Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746
    [Abstract] [Full Text] [Related]

  • 14. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas.
    Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P.
    Br J Surg; 2001 Mar; 88(3):376-81. PubMed ID: 11260102
    [Abstract] [Full Text] [Related]

  • 16. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB.
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [Abstract] [Full Text] [Related]

  • 17. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
    Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, Han JK, Kim WH, Lee YJ, Kim SC, Han DJ, Kim YI, Choi SH, Cho BH, Yu HC, Yoon DS, Lee WJ, Lee KB, Kim YC, Lee KS, Kim MW, Kim HJ, Kim HJ, Park YH.
    Ann Surg Oncol; 2005 Feb; 12(2):124-32. PubMed ID: 15827792
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathologic features of re-resected cases of intraductal papillary mucinous neoplasms (IPMNs).
    Yokoyama Y, Nagino M, Oda K, Nishio H, Ebata T, Abe T, Igami T, Nimura Y.
    Surgery; 2007 Aug; 142(2):136-42. PubMed ID: 17689677
    [Abstract] [Full Text] [Related]

  • 19. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas.
    Wada K, Kozarek RA, Traverso LW.
    Am J Surg; 2005 May; 189(5):632-6; discussion 637. PubMed ID: 15862510
    [Abstract] [Full Text] [Related]

  • 20. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.
    Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Tanizawa Y.
    Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.